---
---

# 42 U.S.C., USLM ref /us/usc/t42/s285a–10

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../../../../..//us/usc/t42/ch6A/schIII/ptC/spt1/m__us_usc_t42_s285a–9.md) | [Next](./../../../../../../..//us/usc/t42/ch6A/schIII/ptC/spt1/m__us_usc_t42_s285a–11.md) | [Root of Title](./../../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs285a%E2%80%9310)

## § 285a–10. Research, information, and education with respect to blood cancer

    (a) __Joe Moakley Research Excellence Program__ 

        (1) __In general__ 

            The Director of NIH shall expand, intensify, and coordinate programs for the conduct and support of research with respect to blood cancer, and particularly with respect to leukemia, lymphoma, and multiple myeloma.

        (2) __Administration__ 

            The Director of NIH shall carry out this subsection through the Director of the National Cancer Institute and in collaboration with any other agencies that the Director determines to be appropriate.

    (b) __Geraldine Ferraro Cancer Education Program__ 

        (1) __In general__ 

            The Secretary shall direct the appropriate agency within the Department of Health and Human Services, in collaboration with the Director of NIH, to establish and carry out a program to provide information and education for patients and the general public with respect to blood cancer, and particularly with respect to the treatment of leukemia, lymphoma, and multiple myeloma.

        (2) __Administration__ 

            The Agency determined by the Secretary under paragraph (1) shall carry out this subsection in collaboration with private health organizations that have national education and patient assistance programs on blood-related cancers.

([July 1, 1944, ch. 373][/us/act/1944-07-01/ch373], title IV, § 417D, as added [Pub. L. 107–172, § 3][/us/pl/107/172/s3], May 14, 2002, [116 Stat. 541][/us/stat/116/541]; amended [Pub. L. 109–482, title I, § 103(b)(17)][/us/pl/109/482/s103/b/17], Jan. 15, 2007, [120 Stat. 3688][/us/stat/120/3688].)

 __Codification__ 

    [Section 3 of Pub. L. 107–172][/us/pl/107/172/s3], which directed that section 417D (this section) be inserted after section 419C of part C of title IV of the Public Health Service Act, was executed by adding section 417D to part C of title IV of the Public Health Service Act, to reflect the probable intent of Congress, notwithstanding that part C does not contain a section 419C.

 __Amendments__ 

    2007—Subsec. (a)(3). [Pub. L. 109–482, § 103(b)(17)(A)][/us/pl/109/482/s103/b/17/A], struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there is authorized to be appropriated such sums as may be necessary for fiscal year 2002 and each subsequent fiscal year. Such authorizations of appropriations are in addition to other authorizations of appropriations that are available for such purpose.”

    Subsec. (b)(3). [Pub. L. 109–482, § 103(b)(17)(B)][/us/pl/109/482/s103/b/17/B], struck out heading and text of par. (3). Text read as follows: “For the purpose of carrying out this subsection, there is authorized to be appropriated such sums as may be necessary for fiscal year 2002 and each subsequent fiscal year. Such authorizations of appropriations are in addition to other authorizations of appropriations that are available for such purpose.”

 __Effective Date of 2007 Amendment__ 

    Amendment by [Pub. L. 109–482][/us/pl/109/482] applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see [section 109 of Pub. L. 109–482][/us/pl/109/482/s109], set out as a note under [section 281 of this title][/us/usc/t42/s281].

 __Congressional Findings__ 

[Pub. L. 107–172, § 2][/us/pl/107/172/s2], May 14, 2002, [116 Stat. 541][/us/stat/116/541], provided that: 

> “Congress finds that:

>     “(1) An estimated 109,500 people in the United States will be diagnosed with leukemia, lymphoma, and multiple myeloma in 2001.

>     “(2) New cases of the blood cancers described in paragraph (1) account for 8.6 percent of new cancer cases.

>     “(3) Those devastating blood cancers will cause the deaths of an estimated 60,300 persons in the United States in 2001. Every 9 minutes, a person in the United States dies from leukemia, lymphoma, or multiple myeloma.

>     “(4) While less than 5 percent of Federal funds for cancer research are spent on those blood cancers, those blood cancers cause 11 percent of all cancer deaths in the United States.

>     “(5) Increased Federal support of research into leukemia, lymphoma, and multiple myeloma has resulted and will continue to result in significant advances in the treatment, and ultimately the cure, of those blood cancers as well as other cancers.”

----------

[Previous](./../../../../../../..//us/usc/t42/ch6A/schIII/ptC/spt1/m__us_usc_t42_s285a–9.md) | [Next](./../../../../../../..//us/usc/t42/ch6A/schIII/ptC/spt1/m__us_usc_t42_s285a–11.md) | [Root of Title](./../../../../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs285a%E2%80%9310)

----------
----------

[/us/act/1944-07-01/ch373]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fact%2F1944-07-01%2Fch373
[/us/pl/107/172/s3]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F107%2F172%2Fs3
[/us/stat/116/541]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F116%2F541
[/us/pl/109/482/s103/b/17]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F109%2F482%2Fs103%2Fb%2F17
[/us/stat/120/3688]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F120%2F3688
[/us/pl/107/172/s3]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F107%2F172%2Fs3
[/us/pl/109/482/s103/b/17/A]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F109%2F482%2Fs103%2Fb%2F17%2FA
[/us/pl/109/482/s103/b/17/B]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F109%2F482%2Fs103%2Fb%2F17%2FB
[/us/pl/109/482]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F109%2F482
[/us/pl/109/482/s109]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F109%2F482%2Fs109
[/us/usc/t42/s281]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fs281
[/us/pl/107/172/s2]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fpl%2F107%2F172%2Fs2
[/us/stat/116/541]: https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fstat%2F116%2F541


